Peter Buhl Hjortrup

MD PhD researcher/clinician with special interest in intensive care and septic shock... CLASSIC trial management committee. YNWA

[Nina A-Ranberg @ARanberg]

1/9

#AIDICU trial results on haloperidol vs. placebo for the treatment of delirium in ICU patients @NEJM

Amazing work in 16 ICUs 🇩🇰🇫🇮🏴󠁧󠁢󠁷󠁬󠁳󠁿🇮🇹

Funded by
@Innofond
@regionsjaelland
@regionerne

https://t.co/bh19n2V53A

[Critical Care Reviews @CritCareReviews]

The CLASSIC trial result presentation from #CCR22 is now out
https://t.co/9VmGD3OK1S

➡️Presentation @TineMeyhoff
➡️ Editorial @KathMaitland
➡️ Panel @DavidHarrison80 @Lennie333 @AndersPerner @jon_silversides
Chair Bala Venkatesh

@pbhjortrup @MortenHylander @CRIC_Int_Care

[Intensive Care Medicine @yourICM]

#COVID19 cardiovascular impact in critically ill
➡️pathophysiology behind increased long term risk?
➡️trajectory of US findings?
➡️influence of vaccines/immunomodulatory drugs?
➡️role for prophylaxis?
📖https://t.co/DjNIjAcxY5

Refers to ECHO-COVID study
📖https://t.co/E1XUXGEunA

[Critical Care Reviews @CritCareReviews]

One of the most outstanding questions in critical care is whether patients benefit from IV fluid resuscitation in septic shock.
A thread...
(image shutterstock)
1/16

[Critical Care Reviews @CritCareReviews]

The 532nd Critical Care Reviews Newsletter, bringing you the best critical care research and open access articles from across the medical literature for the week February 14th to 20th, is now out
https://t.co/khd9HZXTub

CCR is supported by @MyIntensiveCare

[CRIC @CRIC_Int_Care]

Only 100 to go in #CLASSICtrial. Restricted vs standard IV fluids in adults w. septic shock. Outstanding work from 31 ICUs 🇩🇰🇨🇭🇸🇪🇳🇴🇨🇿🇮🇹🇧🇪🇬🇧
@AndersPerner @TineMeyhoff @MortenHylander @pbhjortrup

[Peter Buhl Hjortrup @pbhjortrup]

@CritCareReviews Superb planning, execution, and presentation of RADAR2 @jon_silversides and group! Very interesting data - looking much forward to reading the full report.

[Critical Care Reviews @CritCareReviews]

The unedited videos of the first 2 days of #eCCR21 are now available on the (temporary...) website.

I'll get the edited versions up as quick as I can
https://t.co/zgMQNMrTdc

[Peter Buhl Hjortrup @pbhjortrup]

True and effective
@leochacon @SineWichmann @ARanberg @AJKDonline @foxtrot_ea @ole_mathiesen @JSchmcker @ICR311 @Area_Critica_ @EduMed_UK

[Peter Buhl Hjortrup @pbhjortrup]

True and effective
@leochacon @SineWichmann @ARanberg @AJKDonline @foxtrot_ea @ole_mathiesen @JSchmcker @ICR311 @Area_Critica_ @EduMed_UK

[Critical Care Reviews @CritCareReviews]

Just 9 weeks to eCCR21. We start to release the programme this week. Just the 5 major trial results to be hosted, 11 of the best critical care trials of 2020 to be presented by their chief investigators, plus a little more...

All freely live streamed.
#eCCR21

[Ole Mathiesen @ole_mathiesen]

Er du vores næste ph.d. studerende?
Ph.d. studerende søges til Centre of Anaesthesiological Reserach, Anæstesiologisk Afdeling, SUH, Køge via https://t.co/XzxhkzdQ7E https://t.co/QtKWOQ5gfU

[Intensive Care Medicine @yourICM]

#ICU pts receive vast amounts of IV fluids: choosing right solution/volume to avoid harm challenging. Design/conduction of trials complex, lot of unanswered questions: debates not likely to end soon but each high-quality trial is small step toward solution https://t.co/DvkuiH5xu4

[CRIC @CRIC_Int_Care]

Good news in the midst of the pandemic.
The CLASSIC trial is halfway!

Thanks a million to clinical staff, relatives and patients! Trial results will improve outcomes of septic shock.
@AndersPerner @TineMeyhoff @pbhjortrup @MortenHylander @Majkja

[Peter Buhl Hjortrup @pbhjortrup]

@malignuss @CovidSteroid Thanks! You can find the approved protocol here: https://t.co/TxhigpLmxt

[Giuseppe Citerio @Dr_Cit]

Finally a good study on High risk of thrombosis in patients in severe SARS-CoV-2 infection: a multicenter prospective cohort study accepted by @yourICM by @juliehelms available at https://t.co/iYdn6Ya2qI as preproof

[CRIC @CRIC_Int_Care]

500 patients randomized in the AID-ICU trial and thereby halfway - improving outcomes for #icudelirium! Thanks to all our AID-investigators.
@MusaeusPoulsen
@AndersPerner
@BodilSRasmussen

[Giuseppe Citerio @Dr_Cit]

The Surviving Sepsis Campaign guidelines for severe #COVID19 in ICU under review at @yourICM will be available probably before the weekend on the @ESICM website as pre-proof document.

[CRIC @CRIC_Int_Care]

Now >700 patients included in #classictrial - we're still recruiting and we're almost halfway!
Improving outcomes for #septicshock , including that caused by critically ill patients with #SARSCOV2
@AndersPerner @TineMeyhoff @Majkja @MortenHylander @pbhjortrup

[scanFOAM @scanfoam]

Don't forget you can enjoy free talks on cardiac arrest management from world exports over breakfast

https://t.co/jl6ZQzonQd

#FOAMed